20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Global Impact of Iron Deficiency Anemia and the Role of Pharmaceutical Suppliers

Iron Deficiency Anemia (IDA) is a global health challenge, affecting a significant portion of the world's population. Its impact extends from individual well-being, causing fatigue and reduced productivity, to broader economic consequences. Addressing this widespread condition requires not only medical expertise but also a robust supply chain of essential pharmaceuticals. NINGBO INNO PHARMCHEM CO.,LTD. plays a crucial role as an 'Iron Dextran supplier', ensuring access to vital treatments.

The prevalence of IDA is particularly high in developing countries, but it is also a significant concern in developed nations, affecting various demographics including pregnant women, children, and individuals with chronic diseases or poor dietary habits. The 'iron deficiency anemia treatment parenteral' options, such as Iron Dextran, are indispensable for many patients who cannot benefit from oral iron therapy. NINGBO INNO PHARMCHEM CO.,LTD. understands the critical need for consistent quality and availability of these products.

As a manufacturer and supplier, NINGBO INNO PHARMCHEM CO.,LTD. focuses on maintaining high standards for its Iron Dextran, adhering to 'iron dextran USP BP EP FCC standard' requirements. This commitment ensures that the product delivered is safe, effective, and reliable for clinical use. Whether for direct patient treatment or for 'biochemical research' purposes, the quality of the iron dextran is paramount.

The supply chain for pharmaceuticals like Iron Dextran is complex, involving manufacturing, quality control, logistics, and distribution. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to navigating these complexities to meet the demands of healthcare providers globally. By providing accessible 'iron dextran CAS 9004-66-4', the company contributes to the broader effort of managing and reducing the burden of IDA.

In conclusion, the fight against iron deficiency anemia is a continuous effort that relies heavily on the availability of effective treatments and the companies that supply them. NINGBO INNO PHARMCHEM CO.,LTD. stands as a key partner in this endeavor, offering high-quality Iron Dextran and supporting global health initiatives aimed at overcoming IDA.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Safety First: Managing Risks Associated with Iron Dextran Therapy

Next: The Science Behind Mots-C Peptides: A Breakthrough in Anti-Aging and Metabolic Health

All Rights Reserved